Robert Lanza, Chief Scientific Officer at ADVANCED CELL TECHNOLOGY, INC. (ACTC), sold 7,658,300 shares at $0.18 ($1.4M) on 2012-01-23, disclosed to the SEC on 2012-01-25.
Open-market sale of $1.4M ACTC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.18 | 1,000,000 | $180K | 12.5% |
| 2 | $0.19 | 6,658,300 | $1.3M | 87.5% |
| Total | $0.19 avg | 7,658,300 | $1.4M | 100% |
| Filing → |
| ACTC | SELL | 2012-12-18 | $80K | — | Filing → |
| ACTC | SELL | 2012-08-01 | $160K | — | Filing → |
| ACTC | SELL | 2011-09-30 | $109K | — | Filing → |